QuickView for I-kappa-kinase-beta NEMO binding domain (biogroup)

1. L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (2 of 2)
2. L1000 CMAP - T-ALL Jurkat cells with shRNA-mediated gene knockdown
3. L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (1 of 2)
4. L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (1 of 2)
5. Colon tumor gene expression profiling before and after acquired resistance to gemcitabine

There were no matches for I-kappa-kinase-beta NEMO binding domain

There were no clinical trials for I-kappa-kinase-beta NEMO binding domain